BNET Industries
Last Fiscal Year Sales:$342.7M
- Public
- US
Dow Jones Description
Pharmaceuticals Developer & Marketer
CFO & Senior Vice President
James C. HawleyNumber of Employees 540
Contact Information
5775 W Old Shakopee Rd Ste 100
Bloomington, Minnesota 55437
(952) 346-4700
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
JAPAN'S EISAI MARKETS SEDATIVE IN U.S., 1ST FRUIT OF BIOVENTURE BUY
-
Dainippon Sumitomo To Acquire Sepracor For $2.6 Bln - Update
-
Company and People Notes: Merck and Portola Sign Agreement; Eisai Appoints Senior Vice-Presidents; More ...
-
CFOs on the Move: Week Ending July 17
-
Company and People Notes: Merck and Portola Sign Agreement; Eisai Appoints Senior Vice-Presidents; More ...
News & Analysis
Filter by
mgi pharma inc. and software - All News and Analysis
Eisai Commences Cash Tender Offer for All Outstanding Shares of MGI PHARMA
- 2007-12-21
TOKYO & WOODCLIFF LAKE, N.J. -- Eisai Co., Ltd. (Tokyo, TSE 4523), a research-based human health care hhc company, today announced the commencement of its cash tender offer for all outstanding shares of the common stock of MGI PHARMA, Inc. (NASDAQ: MOGN) for US$41.00 per share. The tender offer is...
Emerging Stocks to Watch! January 27, 2005.
- 2005-01-27
M2 PRESSWIRE-27 January 2005-Stock Market Alerts LLC: Emerging Stocks to Watch! January 27, 2005C1994-2005 M2 COMMUNICATIONS LTD RDATE:01272005 Miami, FLA. - Stock Market Alert`s watch list includes: ER Urgent Care Centers (OTC: ERUG), Connetics Corporation (NASDAQ: CNCT), MGi Pharma, Inc. (NASDAQ:...
REMINDER/MGI Pharma to Present At the U.S. Bancorp Piper Jaffray Health Care Conference
- 2002-01-29
News/Assignment Editors REMINDER... for Wednesday (January 30) -- January 30, 2002 Webcast -- MINNEAPOLIS--BUSINESS WIRE--Jan. 23, 2002 MGI PHARMA, INC., (Nasdaq:MOGN) today announced that it will participate in the U.S. Bancorp Piper Jaffray Health Care Conference on Wednesday, January 30, 2002, at 3:00 p.m. EST. MGI's...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| James C. Hawley | CFO & Senior Vice President |
| William F. Spengler | CFO & Executive Vice President |
| Eric Loukas | COO & Executive Vice President |
| Richard J. Rodgers | Senior Vice President and Controller |
| Rick Rogers | Controller |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Edward W. Mehrer | Chair |
| Gilla Kaplan | Board of Directors |
| Lee J. Schroeder | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | CFO & Senior Vice President | Current |
| Manchester Companies, Inc. | Principal | Former |
| University of Minnesota | BS with distinction | Former |
| Organization | Position | Status |
|---|---|---|
| Smith & Wesson Holding Corporation | Executive Vice President & Chief Financial Officer | Current |
| MGI PHARMA Inc. | CFO & Executive Vice President | Current |
| Endo Pharmaceuticals Holdings Inc. | Director | Current |
| MGI PHARMA Inc. | Senior Vice President, Intl & Corp Development | Former |
| The Black & Decker Corporation | Vice President of Finance | Former |
| Endo Pharmaceuticals Holdings Inc. | Elected A Director | Former |
| New York University | MBA degree in accounting | Former |
| Yale University | BA in economics | Former |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | COO & Executive Vice President | Current |
| 3M Company | Former |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | Senior Vice President and Controller | Current |
| MGI PHARMA Inc. | Board of Directors | Current |
| MGI PHARMA Inc. | Controller & Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | Chair | Current |
| Novastar Mortgage, Inc. | Director | Current |
| FBL Financial Group, Inc. | Board of Directors | Current |
| NovaStar Financial, Inc. | Board of Directors | Current |
| Cydex, Inc. | Chief Executive Officer | Former |
| Cydex, Inc. | President | Former |
| Cydex, Inc. | Chief Financial Officer | Former |
| Marion Merrell Dow | Financial and Administrative Officer | Former |
| Winn-Dixie Stores, Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| MGI PHARMA Inc. | Board of Directors | Current |
Executive News
-
CFOs on the Move: Week Ending July 17
-
Abraxis BioScience Appoints CFO
-
Abraxis names new senior vice president and CFO
-
Abraxis BioScience Swizzles CFO
-
Abraxis BioScience Names Rick Rodgers Succeeding David O'Toole As CFO - Update
-
Abraxis BioScience Appoints Rick Rodgers Chief Financial Officer
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express